aTYR PHARMA INC Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
aTYR PHARMA INC quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • aTYR PHARMA INC Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.3M, a 27.7% decline year-over-year.
  • aTYR PHARMA INC Operating Income (Loss) for the twelve months ending June 30, 2024 was -$62.5M, a 30.8% decline year-over-year.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2023 was -$54.9M, a 18.4% decline from 2022.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2022 was -$46.4M, a 36.4% decline from 2021.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2021 was -$34M, a 114% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$54.9M -$8.52M -18.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$46.4M -$12.4M -36.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$34M -$18.1M -114% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$15.9M +$7.07M +30.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$23M +$9.84M +30% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$32.8M +$14.3M +30.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-24
2017 -$47.1M +$10.8M +18.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
2016 -$57.9M -$10.3M -21.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 -$47.6M -$24.1M -102% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-20
2014 -$23.6M -$4.01M -20.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$19.5M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.